Ilhem Guernah

Statistics

Publications

Citations

H-Index

Active since

2005

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cancer Genetics (United States)

Ilhem Guernah is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacology, medicine, and hematologic malignancy pharmacotherapy.

Publications per year

2005–2016

Publications

Role of the proto-oncogene Pokemon in cellular transformation and ARF repression

Takahiro Maeda, Robin M. Hobbs, Taha Merghoub et al. · Nature · 2005 · 400 citations

Life Sciences, Biology, Molecular Biology +12

PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR

Rosa Bernardi, Ilhem Guernah, David Jin et al. · Nature · 2006 · 377 citations

Life Sciences, Cell Biology, Molecular Biology +12

Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes

Virginia M. Klimek, Sophia Fircanis, P. Maslak et al. · Clinical Cancer Research · 2008 · 132 citations · Full text

Medicine, Oncology, Pharmacology +13

Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome

P. Maslak, Suzanne Chanel, Luis H. Camacho et al. · Leukemia · 2005 · 107 citations

Medicine, Pharmacology, Pharmacotherapy +16

Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody

Yongjun Yin, Xiaodi Ren, Craig S. Smith et al. · Disease Models & Mechanisms · 2016 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5